Safety Evaluation of Biotechnologically-derived Pharmaceuticals

Facilitating a Scientific Approach

Nonfiction, Reference & Language, Law, Medical Law & Legislation, Health & Well Being, Medical, Medical Science, Pharmacology
Cover of the book Safety Evaluation of Biotechnologically-derived Pharmaceuticals by , Springer Netherlands
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9789401148764
Publisher: Springer Netherlands Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9789401148764
Publisher: Springer Netherlands
Publication: December 6, 2012
Imprint: Springer
Language: English

Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Considerable investment has been made by both pharmaceutical and biotechnology companies in pharmaceutical products of biotechnology. However, because relatively few of these products have been marketed, lack of relevant experience means that uncertainty still surrounds the most appropriate strategy for their safety evaluation. The 13th CMR International Workshop, held in February 1997, provided the opportunity for regulatory authority and industry experts from Europe, Japan and the USA to share their experiences of designing safety evaluation programmes for specific product classes: colony stimulating factors, growth factors, hormones, interferons, interleukins, monoclonal antibodies for therapeutic use, and gene therapy products. Participants worked together to recommend those studies that should be considered for such safety evaluation, and those that may be unnecessary. These recommendations subsequently made a valuable contribution to the ICH guideline `Safety Studies for Biotechnological Products', which was finalised at ICH 4 in Brussels in July 1997. The Workshop proceedings not only describe the recommendations but also provide the reader with an appreciation of the science behind safety evaluation strategies used by experts, the influence of different regulatory systems on these strategies, and the type of data required by both toxicologists and clinicians before they have sufficient confidence to administer pharmaceutical products of biotechnology to humans.

More books from Springer Netherlands

Cover of the book International Handbook of Mathematics Education by
Cover of the book Street Children and Homeless Youth by
Cover of the book Nanotechnology, the Brain, and the Future by
Cover of the book Terrorism and Counterterrorism by
Cover of the book Adjustment After Migration by
Cover of the book Greek Studies in the Philosophy and History of Science by
Cover of the book Biomedical Light Microscopy by
Cover of the book Quantum Reprogramming by
Cover of the book Justice to Future Generations and the Environment by
Cover of the book Alphonse Merrheim by
Cover of the book Tumors of the Central Nervous System, Volume 4 by
Cover of the book Invertebrate Bacteriology by
Cover of the book Diseases of Cattle in the Tropics by
Cover of the book Biocatalysis by
Cover of the book Goal and Scope Definition in Life Cycle Assessment by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy